Cargando…

Missed clinical clues in patients with pheochromocytoma/paraganglioma discovered by imaging

BACKGROUND: Pheochromocytomas and paragangliomas (PPGLs) are rare but potentially harmful tumors that can vary in their clinical presentation. Tumors may be found due to signs and symptoms, as part of a hereditary syndrome or following an imaging procedure. OBJECTIVE: To investigate potential differ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rogowski-Lehmann, Natalie, Geroula, Aikaterini, Prejbisz, Aleksander, Timmers, Henri J L M, Megerle, Felix, Robledo, Mercedes, Fassnacht, Martin, Fliedner, Stephanie M J, Reincke, Martin, Stell, Anthony, Januszewicz, Andrzej, Lenders, Jacques W M, Eisenhofer, Graeme, Beuschlein, Felix
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215794/ https://www.ncbi.nlm.nih.gov/pubmed/30352425 http://dx.doi.org/10.1530/EC-18-0318

Ejemplares similares

Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma
por: Rao, Dipti, et al.
Publicado: (2017)

Metastatic pheochromocytoma and paraganglioma: signs and symptoms related to catecholamine secretion
por: Li, Minghao, et al.
Publicado: (2021)

Glucocorticoid Excess in Patients with Pheochromocytoma Compared with Paraganglioma and Other Forms of Hypertension
por: Constantinescu, Georgiana, et al.
Publicado: (2020)

Personalized Management of Pheochromocytoma and Paraganglioma
por: Nölting, Svenja, et al.
Publicado: (2021)

Pre- versus post-operative untargeted plasma nuclear magnetic resonance spectroscopy metabolomics of pheochromocytoma and paraganglioma
por: Bliziotis, Nikolaos G., et al.
Publicado: (2021)

THU612 SDHx Pheochromocytoma/Paraganglioma Has Elevation Of Arginine And Lysine Metabolites
por: Ghayee, Hans Kumar, et al.
Publicado: (2023)

Update on Modern Management of Pheochromocytoma and Paraganglioma
por: Lenders, Jacques W. M., et al.
Publicado: (2017)

Metastatic Pheochromocytoma and Paraganglioma: Somatostatin Receptor 2 Expression, Genetics, and Therapeutic Responses
por: Fischer, Alessa, et al.
Publicado: (2023)

Evaluation of Head and Neck Paragangliomas by Computed Tomography in Patients with Pheochromocytoma-Paraganglioma Syndromes
por: Michałowska, Ilona, et al.
Publicado: (2016)

Use of Steroid Profiling Combined With Machine Learning for Identification and Subtype Classification in Primary Aldosteronism
por: Eisenhofer, Graeme, et al.
Publicado: (2020)

MON-199 Targeting Pheochromocytoma/Paraganglioma with Polyamine Inhibitors
por: Ghayee, Hans Kumar, et al.
Publicado: (2020)

Metabolome-guided genomics to identify mutations in isocitrate dehydrogenase, fumarate hydratase and succinate dehydrogenase genes in pheochromocytoma and paraganglioma
por: Richter, Susan, et al.
Publicado: (2018)

Targeting Cyclooxygenase-2 in Pheochromocytoma and Paraganglioma: Focus on Genetic Background
por: Ullrich, Martin, et al.
Publicado: (2019)

Optimizing Genetic Workup in Pheochromocytoma and Paraganglioma by Integrating Diagnostic and Research Approaches
por: Gieldon, Laura, et al.
Publicado: (2019)

Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma
por: Calsina, Bruna, et al.
Publicado: (2023)

Somatic RET mutation in a patient with pigmented adrenal pheochromocytoma
por: Maison, Nicole, et al.
Publicado: (2016)

Silent pheochromocytoma and paraganglioma: Systematic review and proposed definitions for standardized terminology
por: Constantinescu, Georgiana, et al.
Publicado: (2022)

Risk of complications after core needle biopsy in pheochromocytoma/paraganglioma
por: Zhang, Liang, et al.
Publicado: (2023)

Response to Letter to the Editor from Berends et al: “Approach to the Patient: Perioperative Management of the Patient With Pheochromocytoma or Sympathetic Paraganglioma”
por: Berends, Annika M A, et al.
Publicado: (2020)

Cancer Stem Cells in Pheochromocytoma and Paraganglioma
por: Scriba, Laura D., et al.
Publicado: (2020)

Pheochromocytomas and Paragangliomas: Bypassing Cellular Respiration
por: Cascón, Alberto, et al.
Publicado: (2019)

Intricacies of the Molecular Machinery of Catecholamine Biosynthesis and Secretion by Chromaffin Cells of the Normal Adrenal Medulla and in Pheochromocytoma and Paraganglioma
por: Berends, Annika M.A., et al.
Publicado: (2019)

Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma
por: Mellid, Sara, et al.
Publicado: (2023)

The Saline Infusion Test for Primary Aldosteronism: Implications of Immunoassay Inaccuracy
por: Eisenhofer, Graeme, et al.
Publicado: (2021)

Biochemical Diagnosis of Catecholamine-Producing Tumors of Childhood: Neuroblastoma, Pheochromocytoma and Paraganglioma
por: Eisenhofer, Graeme, et al.
Publicado: (2022)

Head/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramine
por: Richter, Susan, et al.
Publicado: (2022)

Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision Medicine
por: Nölting, Svenja, et al.
Publicado: (2019)

Anti-Cancer Potential of MAPK Pathway Inhibition in Paragangliomas–Effect of Different Statins on Mouse Pheochromocytoma Cells
por: Fliedner, Stephanie M. J., et al.
Publicado: (2014)

Mediastinal paragangliomas related to SDHx gene mutations
por: Michałowska, Ilona, et al.
Publicado: (2016)

Analysis of Telomere Maintenance Related Genes Reveals NOP10 as a New Metastatic-Risk Marker in Pheochromocytoma/Paraganglioma
por: Monteagudo, María, et al.
Publicado: (2021)

Pheochromocytomas and secreting paragangliomas
por: Plouin, Pierre-François, et al.
Publicado: (2006)

Extensive patient-to-patient single nucleus transcriptome heterogeneity in pheochromocytomas and paragangliomas
por: Brazda, Peter, et al.
Publicado: (2022)

The role of regulated necrosis in endocrine diseases
por: Tonnus, Wulf, et al.
Publicado: (2021)

Pheochromocytoma/paraganglioma crisis: case series from a tertiary referral center for pheochromocytomas and paragangliomas
por: Meijs, Anouk C, et al.
Publicado: (2021)

Classification of microadenomas in patients with primary aldosteronism by steroid profiling
por: Yang, Yuhong, et al.
Publicado: (2019)

The first Dutch SDHB founder deletion in paraganglioma – pheochromocytoma patients
por: Bayley, Jean-Pierre, et al.
Publicado: (2009)

Interleukin-6 producing pheochromocytoma/paraganglioma: case series from a tertiary referral centre for pheochromocytomas and paragangliomas
por: Meijs, A. C., et al.
Publicado: (2021)

Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma
por: Calsina, Bruna, et al.
Publicado: (2019)

Pheochromocytoma and paraganglioma: imaging characteristics
por: Baez, Juan C., et al.
Publicado: (2012)

Glycemic Disturbances in Pheochromocytoma and Paraganglioma
por: Ronen, Joshua A, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jedpk7nm6ejlqdevsk5udu2n7s